Home

THE TEAM OF MSD BULGARIA PLANTED 56 TREES IN BANSKO

A QUEST TO INVENT
A CALLING TO CURE

DIABETES

We strive for scientific excellence and innovation in all stages of diabetes research.

ONCOLOGY

CREATING NEW PARADIGMS OF TREATMENT
MSD is investing significant resources to develop innovative oncology medicines - a new solution for patients to live longer and with better quality of life.

VACCINES

For more than a century, we bring innovative vaccines that address important unmet health needs.

HIV

MSD’s commitment to HIV: 30 years and counting
Contributing to making a difference in the fight against HIV since 1985’

HEPATITIS C

We are committed to HCV elimination by supporting informed clinical decision making and deliver innovative solutions to facilitate the cascade of care across diverse geographies, health systems and patient groups.

THE SCIENCE OF HEALTHIER ANIMALS

We work to discover, develop and deliver novel animal health products and solutions that improve the health of animals.

At MSD we support maternal health care, following the belief that no mother should die giving birth. Join us to
#EndMaternalMortality
Learn more at:http://www.msdformothers.com
@MSDforMothers

Each year our employees donate hundreds of volunteering hours to help to improve the health and well-being of the community we live in.

MSD Bulgaria maintains healthy collaboration with the academic society and with the future healthcare professionals in Bulgaria.

Forward-Looking Statement

Forward-Looking Statement of MSD & Co., Inc., Kenilworth, NJ, USA

This website of MSD & Co., Inc., Kenilworth, NJ, USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include, but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and healthcare legislation in the United States and internationally; global trends toward healthcare cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2015 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).

No Duty to Update

The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.